Why Dynavax, Novavax, and Inovio Stocks Sank This Week
Shares of several companies involved in the development of COVID-19 vaccines sank this week. As of the market close on Thursday, Dynavax Technologies (NASDAQ: DVAX) stock had dropped 12%, and shares of Novavax (NASDAQ: NVAX) and Inovio Pharmaceuticals (NASDAQ: INO) were down 15.5% and 15.8%, respectively.
None of these companies announced any news this week. Instead, the stocks likely fell due to the decision by the Biden administration to push for third booster doses of messenger RNA (mRNA) vaccines made by Pfizer-BioNTech and Moderna. This move could increase the uncertainty about the future for COVID-19 vaccines that haven't yet reached the market.
Image source: Getty Images.
Source Fool.com
